Skip to main navigation

Beam - Top Menu

About Us
Our Science
Our Portfolio
Investor Center
Careers
Contact

Investor Center

Investors & Media

Overview
Press Releases
Events & Presentations
Publications
Financials & Filings
- SEC Filings
- Annual Reports
Stock Information
- Stock Quote & Chart
Analyst Coverage
Corporate Governance
Investor FAQs
Contact Us

Stockholder Tools

Print Page
RSS Feeds
Share Page
Email Alerts

Press Releases

Year

January 5, 2021

Beam Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will present at the 39 th Annual J.P.

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 11 of 11

Investors & Media

Overview
Press Releases
Events & Presentations
Publications
Financials & Filings
- SEC Filings
- Annual Reports
Stock Information
- Stock Quote & Chart
Analyst Coverage
Corporate Governance
Investor FAQs
Contact Us

Stockholder Tools

Print Page
RSS Feeds
Share Page
Email Alerts

Beam - Top Menu

About Us
Our Science
Our Portfolio
Investor Center
Careers
Contact

Privacy Policy

Facebook
Twitter
LinkedIn